A 4-year study found that the combination of two cholesterol-lowering drugs -- Zocor (a statin) plus Zetia -- did not reduce the total risk of death.

In fact, the overall death rate was 4% higher in people given these drugs.

This may have been due to random chance, but at the very least, it shows that that these drugs did absolutely no good whatsoever.

But wait. There's more. Read the entire article | Email this article

How many doctors and patients would view the recommendations on cholesterol differently if they knew that 8 out of 9 of the scientists on the National Cholesterol Education Program (NCEP) panel, which is a group from the U.S. National Institutes of Health (NIH) that has issued national recommendations on cholesterol levels and who should be taking these drugs, have taken money or stocks or stock options by the drug companies selling these drugs? Read the entire article | Email this article

This 4-year study found that the combination of two cholesterol-lowering drugs - Zocor (a statin) plus Zetia - did NOT reduce the total risk of death.

In fact, the overall death rate was 4% higher in people given these drugs.

This may have been due to random chance, but at the very least, it shows that that these drugs did absolutely no good whatsoever.

People given these drugs had 48% more cancer ( 105 cases versus 70 cases ).

People given these drugs had 64% more cancer deaths ( 39 deaths versus 23 deaths ).

( This is the 3rd video highlight from this paper. ) Read the entire article | Email this article